IUPAC/Chemical Name
D-Alanine, N-((5-((4,6-dideoxy-3-O-beta-D-glucopyranosyl-4-(methylamino)-beta-D-galactopyranosyl)oxy)-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo(a)naphthacen-2-yl)carbonyl)-, (5S-trans)-
InChi Key
GHJAVLVTKGUJCU-HBYOQVLJSA-N
InChi Code
InChI=1S/C41H46N2O19/c1-11-6-18-24(31(50)21(11)38(55)43-12(2)39(56)57)23-16(9-17-25(32(23)51)28(47)15-7-14(58-5)8-19(45)22(15)27(17)46)29(48)36(18)61-41-35(54)37(26(42-4)13(3)59-41)62-40-34(53)33(52)30(49)20(10-44)60-40/h6-9,12-13,20,26,29-30,33-37,40-42,44-45,48-54H,10H2,1-5H3,(H,43,55)(H,56,57)/t12-,13-,20-,26+,29+,30-,33+,34-,35-,36+,37+,40+,41+/m1/s1
SMILES Code
C[C@H](C(O)=O)NC(C1=C(C)C=C([C@H](O[C@H]2[C@@H]([C@H]([C@@H](NC)[C@@H](C)O2)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)O)[C@@H](O)C(C=C4C(C5=C6C=C(OC)C=C5O)=O)=C7C(O)=C4C6=O)C7=C1O)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
870.81
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Saitoh K, Tsuno T, Kakushima M, Hatori M, Furumai T, Oki T. Pradimicin S, a new pradimicin analog. II. Isolation and structure elucidation. J Antibiot (Tokyo). 1993 Mar;46(3):406-11. doi: 10.7164/antibiotics.46.406. PMID: 8267791.
2: Hiramoto F, Nomura N, Furumai T, Igarashi Y, Oki T. Pradimicin-resistance of yeast is caused by a point mutation of the histidine-containing phosphotransfer protein Ypd1. J Antibiot (Tokyo). 2003 Dec;56(12):1053-7. doi: 10.7164/antibiotics.56.1053. PMID: 15015733.
3: Saitoh K, Furumai T, Oki T, Nishida F, Harada K, Suzuki M. Pradimicin S, a new pradimicin analog. III. Application of the frit-FAB LC/MS technique to the elucidation of the pradimicin S biosynthetic pathway. J Antibiot (Tokyo). 1995 Feb;48(2):162-8. doi: 10.7164/antibiotics.48.162. PMID: 7706128.
4: Saitoh K, Sawada Y, Tomita K, Tsuno T, Hatori M, Oki T. Pradimicins L and FL: new pradimicin congeners from Actinomadura verrucosospora subsp. neohibisca. J Antibiot (Tokyo). 1993 Mar;46(3):387-97. doi: 10.7164/antibiotics.46.387. PMID: 8478257.